medication compliance
Pred Forte
Instructed in new medication Pred Forte to manage inflammation of palpebral and bulbar conjunctiva, cornea and anterior segment of globe. In addition, warned of possible S/E, such as, increased intraocular pressure, thinning of cornea, interference with corneal wound healing, increased susceptibility to viral or fungal corneal infections, corneal ulceration, discharge, discomfort, foreign body sensation, glaucoma exacerbation, cataracts, visual acuity and visual field defects, optic nerve damage with excessive or long-term use, systemic effects, and adrenal suppression with excessive or long-term use. Instructed to wash hands before and after installation and warned not to touch tip of dropper to eye or surrounding area. Apply light finger pressure on lacrimal sac for 1 minute after installation. On long-term therapy, have frequent tests of intraocular pressure. Instructed not to share drug, washcloths, or towels with family members, and notify MD if anyone develops same signs or symptoms. Stress importance of compliance with recommended therapy. Notify MD if improvement does not occur within several days or if pain, itching, or swelling of eye occurs. Instructed not to use leftover drug for new eye inflammation because serious problems may occur.